Sign in

CIK 0001601485

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113430072
Phone
+1 857-209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-16 Haqq Christopher Grant or award · Stock Option (Right to Buy) +64,643 64,643
2026-02-02 Haqq Christopher Grant or award +25,400 57,381
2026-02-02 Haqq Christopher Grant or award · Stock Option (Right to Buy) +50,900 50,900
2025-02-03 Haqq Christopher Grant or award · Stock Option (Right to Buy) +44,000 44,000
2024-09-30 Haqq Christopher Grant or award · Stock Option (Right to Buy) +28,200 28,200
2024-02-01 Haqq Christopher Grant or award · Stock Option (right to buy) +28,200 28,200

Page 1 of 1 · 6 trades